Twenty four hours post a single administration of EJHE or EJHE-WR (10 μg) did not modulate spleen or tumor IFN-γ, TGF-β and IL-17 production levels in tumor-bearing mice (Figure 3A &3B). Here, IL17A is linked to neoplasm.